Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2019 October;110(5) > Minerva Medica 2019 October;110(5):450-4

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Medica 2019 October;110(5):450-4

DOI: 10.23736/S0026-4806.19.06095-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

The clinical presentation in adulthood of juvenile idiopathic arthritis

Marta PRIORA , Simone PARISI, Maria C. DITTO, Richard BORRELLI, Clara L. PERONI, Angela LAGANÀ, Enrico FUSARO

Division of Rheumatology, A.O.U. “Città della Salute e della Scienza”, Turin, Italy



Juvenile idiopathic arthritis (JIA) is a chronic systemic inflammatory disease, which affects children and adolescents, characterized by significant differences when compared to inflammatory rheumatisms in adulthood. Today, in a panorama enriched in the last decades with great improvements in the diagnostic and therapeutic field, a far from negligible portion and an increasing number of patients with JIA require the continuation of treatments in adulthood. This specific population of patients, given the high incidence of extra-articular manifestations, residual irreversible disabilities, comorbidities related to an inflammatory process and extended immunosuppressive treatments during the age of development, requires precise attentions in the follow-up and a multidisciplinary approach characterized by different clinical, psychological and social aspects.


KEY WORDS: Arthritis, juvenile; Treatment outcome; Adult

inizio pagina